Statistical Analysis Plan: Clinical trial of Zoledronic acid (Aclasta) in children and adolescents with Duchenne muscular dystrophy

2020-07-23T01:50:58Z (GMT) by Katherine Lee Xiaofang Wang
This document presents the approved version of the statistical analysis plan for the Clinical trial of Zoledronic acid (Aclasta) in children and adolescents with Duchenne muscular dystrophy